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Reconstructive trends and complications
following parotidectomy: incidence and
predictors in 11,057 cases
Cory Donovan Bovenzi* , Peter Ciolek, Meghan Crippen, Joseph M. Curry, Howard Krein and Ryan Heffelfinger

Abstract
Background: Parotidectomy is a common treatment option for parotid neoplasms and the complications associated
with this procedure can cause significant morbidity. Reconstruction following parotidectomy is utilized to address
contour deformity and facial nerve paralysis. This study aims to demonstrate national trends in parotidectomy patients
and identify factors associated with adverse postoperative outcomes. This study includes the largest patient database
to date in determining epidemiologic trends, reconstructive trends, and prevalence of adverse events following
parotidectomy.
Methods: A retrospective review was performed for parotidectomies included in the ACS-NSQIP database between
January 2012 and December 2017. CPT codes were used to identify the primary and secondary procedures performed.
Univariate and multivariate analysis was utilized to determine associations between pre- and perioperative variables
with patient outcomes. Preoperative demographics, surgical indications, and common medical comorbidities were
collected. CPT codes were used to identify patients who underwent parotidectomy with or without reconstruction.
These pre- and perioperative characteristics were compared with 30-day surgical complications, medical complications,
reoperation, and readmission using uni- and multivariate analyses to determine predictors of adverse events.
Results: There were 11,057 patients who underwent parotidectomy. Postoperative complications within 30 days were
uncommon (1.7% medical, 3.8% surgical), with the majority of these being surgical site infection (2.7%). Free flap
reconstruction, COPD, bleeding disorders, smoking, and presence of malignant tumor were the strongest independent
predictors of surgical site infection. Readmission and reoperation were uncommon at an incidence of 2.1% each. The
strongest factors predictive of readmission were malignant tumor and corticosteroid usage. The strongest factors
predictive of reoperation were free flap reconstruction, malignant tumor, bleeding disorder, and disseminated cancer.
Surgical volume/contour reconstruction was relatively uncommon (18%). Facial nerve sacrifice was uncommon (3.7%)
and, of these cases, only 25.5% underwent facial nerve reinnervation and 24.0% underwent facial reanimation.
Conclusions: There are overall low rates of complications, readmissions, and reoperations following parotidectomy.
However, certain factors are predictive of adverse postoperative events and this data may serve to guide management
and counseling of patients undergoing parotidectomy. Concurrent reconstructive procedures are not commonly
reported which may be due to underutilization or underreporting.
Keywords: Parotidectomy, Complications, Facial nerve, NSQIP, Reconstruction, Epidemiology, Readmission, Contour,
Comorbidities, Infection
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Background
Parotid neoplasms are rare entities which comprise less
than 3% of head and neck tumors. Management is primarily surgical, and depending on the extent and severity of
disease, ranges from a superficial parotidectomy to a radical parotidectomy with facial nerve sacrifice [1]. There is
ample data pertaining to site specific morbidity following
parotidectomy (e.g. facial nerve weakness, salivary fistula,
and Frey’s syndrome); however, the literature on general
postoperative surgical morbidity following parotidectomy
is lacking [2].
In the era of quality metrics, there is an ever-growing
focus on improving surgical and postsurgical care, while
reducing complications and cost. In 2001, The American
College of Surgeons (ACS) piloted the first iteration of the
National Surgical Quality Improvement Program (NSQIP)
in the private hospital sector. The NSQIP database collects
over 130 patient variable including preoperative risk factors, intraoperative variables, and postoperative complications. This data can be used by hospitals to track, analyze,
and compare the quality of surgical care in a risk-adjusted
manner. Currently, over 700 hospitals including 8 of the
top 10 hospitals as ranked by the US News & world report
participate in the program [3, 4].
Currently, the majority of literature pertaining to the
outcomes and trends in parotidectomy are limited to
single institution or small multi-institutional studies.
Our investigation aims to provide a reference for national trends in parotidectomy surgery including patient
demographics, pre-operative comorbidities, operative
variables, and postoperative outcomes.
Methods
Data and study cohort

This is a retrospective analysis of the parotidectomy cases
using the NSQIP participant user files from January 2012
through December 2017. The database was queried for all
cases with the following Current Procedural Terminology
(CPT) codes: 42410, 42,415, 42,420, 42,425, and 42,426.
The resultant cohort was characterized by rates of patient
characteristics, comorbidities, operative characteristics,
and 30-day postoperative complications.
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(requiring medication), dyspnea (on exertion or at rest),
corticosteroid use (< 30 days prior to surgery), surgical site
infection, non-independent functional status, and a number of additional preexisting medical conditions [5]. Obesity was defined as BMI (body mass index) > 30, derived
from height and weight variables.
Operative characteristics

Cases were further analyzed for operative characteristics.
Variables including inpatient versus outpatient status, surgical specialty performing the parotidectomy (otolaryngology- head and neck surgery, general surgery, plastic
surgery, and other), and total operative time were directly
defined by NSQIP [5]. The principal parotidectomy CPT
code was used to determine procedure extent (total vs.
superficial) and management of the facial nerve (not dissected, dissected and preserved, sacrificed, and unknown).
Additionally using CPT codes, rates of concurrent procedures were examined such as neck dissection, nerve monitoring, free flap, other volume restoration, reinnervation,
and reanimation. Procedure type and associated CPT
codes are given in Additional file 1 Table S1.
Outcome variables

Operative outcomes were assessed including rates of 30day surgical complications, medical complications, reoperation, readmission, and length of hospital stay. Specific surgical complications include superficial surgical site infection
(SSI), deep SSI (defined as “deep” or “organ space” SSI),
wound dehiscence, and hemorrhage/hematoma formation.
Specific medical complications include cardiac arrest, myocardial infarction, stroke, ventilator requirement > 48 h,
pneumonia, and various others enumerated in Table 3.
All complication variables were coded by NSQIP [5]
with the exception of hemorrhage/hematoma, which was
derived from the relevant ICD-9 and 10 codes given for
readmission or reoperation diagnosis (Additional file 1
Table S1). The occurrence of this complication therefore
refers to cases requiring reoperation or readmission for
postoperative hemorrhage or hematoma formation
within 30 days of the principal procedure.
Statistical analysis

Patient characteristics

Patient demographics examined included age, sex, and
race. The indication for parotidectomy was elicited using
the International Classification of Disease (ICD) version 9
or 10 code given for postoperative diagnosis and grouped
into five major categories: malignant tumor, benign
tumor, tumor not otherwise specified (NOS), other disease
of parotid, and unclassified (Additional file 1 Table S1).
Comorbidities defined by NSQIP include smoking (within
the year prior to admission), weight loss (> 10% body
weight in the 6 months prior to surgery), hypertension

Descriptive statistics were used to summarize by rates of
patient characteristics, comorbidities, operative characteristics, and 30-day postoperative complications across
the study cohort. In order to identify the patient and
procedure characteristics associated with an increased
risk for postoperative morbidity, binary logistic regression was performed. A regression model was generated
to account for patient demographics, comorbidities, procedure extent, indication, setting, surgical specialty, and
concurrent procedures. All comorbidities occurring at a
rate of ≥0.5% of the overall cohort were included. Cases
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with unknown values were excluded, leaving 8811 cases
for analysis. Regression analysis was performed for each
complication occurring at a rate of ≥0.5%, including
wound dehiscence, surgical site infection, hemorrhage/
hematoma, overall surgical and medical complications,
readmission, and reoperation. All variables found to be
significantly associated with each of these complications
are listed in Table 4.
All statistical analyses were performed using SPSS
(Statistical Package for the Social Sciences), version 23
(IBM, Armok, NY). P-values of < 0.05 were considered
to be statistically significant. This analysis was determined to be exempt from Institutional Review Board approval due to the de-identified nature of the dataset.

Results
A total of 11,057 patients were identified as having
undergoing parotidectomy between January 1, 2012 and
December 31, 2017. Of these patients, the majority were
male (53.0%), white (70.4%), and ages 61–70 (26.6%). In
this cohort, parotidectomy was most commonly performed for benign neoplasms (45.2%), followed by malignant neoplasms (29.7%) and tumors of uncertain
significance (13.0%). Parotidectomy was indicated for
non-neoplastic disease (e.g. chronic parotitis) in 8.8% of
cases. Examination of various patient comorbidities
found hypertension (45.4%), obesity (39.7%), and smoking (23.5%) to be most common (Table 1). Patients
undergoing parotidectomy for benign lesions were significantly more likely to be smokers compared to those
undergoing parotidectomy for malignant lesions (30.5%
vs. 13.9%, p < 0.001). This may represent a preponderance of Warthin’s tumors in smokers.
In this cohort, superficial parotidectomy was performed 2.4 times more frequently than total parotidectomy. Concurrent neck dissection was performed in
19.9% of cases. Reconstruction involving volume restoration was performed in 12.4% of cases, including free
flaps (3.6%), local flaps (5.4%), fat/dermal grafts (2.0%),
and allografts (1.8%) (Table 2). Total parotidectomy
cases were significantly more likely to involve a concurrent volume restoration procedure compared to superficial parotidectomy (17.8% vs. 10.3%, p < 0.001). Facial
nerve sacrifice was recorded in 3.7% of cases (Table 2).
In this subset of patients, 25.5% underwent a concurrent
reinnervation procedure, and 24.0% underwent a concurrent reanimation procedure (Table 2).
Overall, 5.1% of patients experienced a postoperative
complication within 30 days of the procedure. The majority were surgical complications, occurring in 3.8% of patients. Surgical site infection occurred most commonly,
with 1.9% developing a superficial SSI, and 0.8% of patients developing a deep SSI. Unplanned reoperation was
observed in 2.1% of cases. Medical complications occurred
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Table 1 Demographics and Patient Characteristics
N

%

< 50

2772

25.3

51–60

2389

21.6

61–70

2920

26.6

Age

71–80

1977

18.0

> 80

902

8.2

Male

5862

53.0

Female

5195

47.0

Sex

Race
White

7784

70.4

Black

713

6.4

Other

703

6.4

Unknown

1857

16.8

Malignant tumor

3288

29.7

Benign tumor

4995

45.2

Tumor Not Otherwise Specified

1433

13.0

Surgical Indication

Other disease of parotid

977

8.8

Other/unknown

364

3.3

248

2.2

Comorbidities
Bleeding disorder
Diabetes

1707

15.4

On dialysis

39

0.4

Disseminated cancer

364

3.3

Dyspnea

536

4.8

Dependent functional status

129

1.2

Congestive Heart Failure

29

0.3

Chronic Obstructive Pulmonary Disease

518

4.7

Hypertension

5019

45.4

Obesity (BMI > 30)

3857

39.7

Smoker

2602

23.5

Corticosteroids

363

3.3

Wound infection

155

1.4

Weight loss

68

0.6

ASA class
1 (No disturbance)

990

9.0

2 (Mild disturbance)

5355

48.5

3 (Severe disturbance)

4395

39.8

4 (Life threatening)

307

2.8

in 1.7% of patients, the most common of these being
pneumonia (0.4%) and urinary tract infection (0.4%). The
mean length of stay was 1.65 days with an unplanned 30day readmission rate of 2.1% (Table 3). On binary logistic
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Table 2 Operative Characteristics

Table 3 Complication Rates Following Parotidectomy

Non-Reconstructive Operative Characteristics

N
N

Superficial

3229
7828

%

Medical Complications, Overall

186

1.7

Cardiac arrest

13

0.1

29.2

Myocardial Infarction

22

0.2

70.8

Stroke

24

0.2

%

Parotidectomy extent
Total
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Management of facial nerve

Reintubation

35

0.3

27

0.2

Not dissected

1683

15.2

Ventilator-dependent > 48 h

Dissected and preserved

8575

77.6

Sepsis/septic shock

33

0.3

49

0.4

Sacrificed

405

3.7

Pneumonia

Unknown

394

3.6

Pulmonary Embolism

13

0.1

Acute Kidney Injury

14

0.1

19.9

Urinary Tract Infection

43

0.4

2.4

Deep Vein Thrombosis

20

0.2

Surgical Complications, Overall

418

3.8

50

0.5

Concurrent procedures
Neck dissection
Nerve monitoring

2204
263

Surgeon specialty
Otolaryngology

10,094

91.3

Wound disruption

General Surgery

745

6.7

Superficial SSI

209

1.9

84

0.8

Plastic Surgery

180

1.6

Deep SSI

Other

38

0.3

Hemorrhage/Hematoma

100

0.9

Unplanned Readmission

236

2.1

37.4

Unplanned Reoperation

234

2.1

62.6

Length of Stay, mean [SD] (days)

1.65 [4.00]

Setting
Inpatient

4130

Outpatient

6927

Operative time, mean [SD] (min)

185.3 [141.9]

Utilization of Reconstructive Procedures
N

%

Free flap

393

3.6

Other volume restoration

998

9.0

Reinnervation

205

1.9

Reanimation

124

1.1

regression, various patient and procedure related characteristics were found to be independently associated with
an increased risk of medical and surgical complications.
Of the demographic variables assessed, increasing age was
found to be significantly associated with increasing risk
for overall medical complications but was not associated
with surgical complications (Additional file 2 Table S2).
Relative to those with a benign neoplasm, patients
undergoing parotidectomy for a malignant neoplasm were
found to be at significantly higher risk for overall surgical
and medical complications as well as reoperation and readmission (Additional file 2 Table S1). Both smoking and
COPD (chronic obstructive pulmonary disease) were independently predictive of wound dehiscence and surgical
site infection. Of the concurrent procedures examined,
only volume restoration procedures were predictive of
surgical complications. Free flap procedures were independently associated with the highest risk for overall surgical complications with an odds ratio of 2.87 (Table 4).

Neck dissection, reanimation, and reinnervation procedures were not found to significantly increase risk for any
measure of postoperative morbidity (Table 5).
SSI = surgical site infection, SD = standard deviation.

Discussion
To date, this is the most robust dataset to evaluate national
trends in parotidectomy surgery. The post-parotidectomy
complication rates seen here are the most substantial information available to counsel patients with, and are the most
thorough and recent data available thus far. There has been
a review of the NSQIP data from 2006 to 2011 which evaluated 2919 patients which also reported low rates of medical
and surgical complications [6]. In addition to evaluating a
newer and larger dataset, the current study is likely to be of
increased validity, as NSQIP removed several unreliable
outcomes variables from the dataset in 2012 [5]. The data
here correspond to existing literature that postparotidectomy medical and surgical complications increase
with increasing age [7, 8]. However, the rate of surgical site
complications seen here are lower than that of those reported in some single-center studies [9], which highlights
the institutional differences in complication rates, and the
national average estimated with this study may become an
important standard for quality of care assessments at an institutional level. The difference in complication rates is an
important feature for further investigation as comparison of
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Table 4 Multivariable Logistic Regression of Adverse Events
Following Parotidectomy, Significant Variables
OR

95% CI
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p

Table 5 Multivariable Logistic Regression of Adverse Events
Following Parotidectomy: Odds Ratios Associated with
Reconstructive Procedures
Surgical site infection

Surgical site infection

OR

95% CI

p

Male

1.41

1.01–1.96

0.042

Bleeding disorder

2.21

1.20–4.07

0.011

Free flap reconstruction

2.87

1.67–4.93

< 0.001

1.66

1.07–2.57

0.025

Diabetes

1.66

1.17–2.37

0.005

Other volume restoration

COPD

2.08

1.25–3.45

0.005

Reinnervation

0.93

0.42–2.22

0.961

Reanimation

0.94

0.35–2.62

0.959

3.25

1.39–7.58

0.006

Hypertension

1.53

1.08–2.16

0.017

Smoking

1.85

1.32–2.59

< 0.001

Malignant tumor

1.70

1.09–2.67

0.021

Free flap reconstruction

Free flap reconstruction

2.87

1.67–4.93

< 0.001

Other volume restoration

3.39

1.60–7.19

0.001

0.025

Reinnervation

0.47

0.12–2.66

0.563

Reanimation

1.90

0.50–7.25

0.350

Other volume restoration

1.66

1.07–2.57

Wound Dehiscence

Wound Dehiscence

Hemorrhage/Hematoma

COPD

2.65

1.03–6.87

0.044

Smoking

2.58

1.23–4.34

0.013

Free flap reconstruction

3.13

1.43–6.83

0.004

1.02

0.46–2.27

0.962

Malignant tumor

4.33

1.36–13.77

0.013

Other volume restoration

Other disease of parotid

5.31

1.51–18.71

0.009

Reinnervation

0.42

0.12–2.46

0.537

Reanimation

2.11

0.63–7.05

0.227

1.29

0.72–2.32

0.399

Free flap reconstruction

3.25

1.39–7.58

0.006

Other volume restoration

3.39

1.60–7.19

0.001

Free flap reconstruction

Hematoma/seroma
Free flap reconstruction

3.13

1.43–6.83

0.004

Readmission
Disseminated cancer

Readmission

2.02

1.30–3.15

0.002

Other volume restoration

1.24

0.79–1.97

0.353

Reinnervation

0.72

0.28–1.86

0.493

Reanimation

1.18

0.44–3.18

0.749

Reoperation

Hypertension

1.44

1.05–1.97

0.023

Corticosteroids

2.62

1.69–4.07

< 0.001

Free flap reconstruction

3.56

2.30–5.50

< 0.001

1.50

0.95–2.38

0.083

Wound infection

2.07

1.10–3.90

0.025

Other volume restoration

Malignant tumor

3.00

1.94–4.65

< 0.001

Reinnervation

1.03

0.51–2.07

0.937

0.003

Reanimation

1.30

0.62–2.72

0.481

Other disease of parotid

2.21

1.31–3.75

OR = odds ratio, CI = confidence interval.

Reoperation
Bleeding disorder

1.82

1.02–3.26

0.044

Disseminated cancer

1.66

1.01–2.71

0.044

Malignant tumor

2.64

1.65–4.20

< 0.001

Free flap reconstruction

3.56

2.30–5.50

< 0.001

OR = odds ratio, CI = confidence interval.

quality of care becomes increasingly important. While one
may assume that high volume centers would have lower
complication rates, in parotidectomy for benign disease, a
previous study has shown that surgeon experience did not
seem to be associated with complication rates- however, at
that institution they admit that more complicated cases
were reserved for more experienced surgeons [10].
There is a significant body of research available evaluating
single-site experiences with common complications after
parotidectomy. These studies are mostly limited to facial
paresis, Frey syndrome, hypoesthesia, and contour deformity. Unfortunately, this dataset did not capture these complications. However, there is evidence that parotidectomy

reconstructive techniques may mitigate some of these adverse outcomes.
Facial paresis following parotidectomy is a common
finding that is typically self-limiting and limited to marginal mandibular nerve weakness [11]. This risk may be
mitigated by performing a limited surgical approach
[12–14], or if there is reconstruction with a muscular
flap, with or without an abdominal fat graft [15, 16]. Frey
syndrome is a historically common complication following parotidectomy described as gustatory sweating due
to aberrant reinnervation of secretory parasympathetic
fibers from parotid tissue to dermal tissue. Reconstructive procedures that provide a barrier between parotid
tissue and the dermal surface have been shown to decrease the incidence of Frey Syndrome [15, 17–20].
These reconstructions include rotating a sternocleidomastoid flap into the defect, elevating a superficial musculoaponeurotic flap prior to performing parotidectomy,
grafting free abdominal fat, and insertion of acellular
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dermis. There is continued debate on the most effective
reconstruction method. A meta-analysis on the subject
suggests that all of the above interventions decrease Frey
syndrome but acellular dermis implants may be associated with higher infection rates [14].
These reconstruction options also help improve postoperative facial symmetry, especially in cases of total
parotidectomy. Parotidectomy, as a common procedure
performed in a highly cosmetic region is uniquely poised
to benefit from advances in maintaining symmetric volume and minimizing visible scarring. Adequate exposure
and improved scar cosmesis has been shown to follow
from the trend of utilizing a facelift incision in parotidectomy [21, 22]. Following large parotidectomy defects
encountered in total parotidectomy and radical parotidectomy, muscular flaps and fat grafting have shown to
reduce contour asymmetry [16, 22, 23]. Additionally, another level of complexity occurs when parotidectomy requires concurrent skin and/ or facial nerve sacrifice
which typically is necessary in cases of malignant lesions
with adjacent tumor invasion. Fortunately, multiple reconstructive options exist for these defects- for skin and
soft tissue reconstruction, anterolateral thigh free flaps
have been the mainstay of treatment due to the large
vessel caliber available for microvascular anastomosis
and variable size and shape available with this option
[24–27]. Additionally, if the patient requires postoperative radiation, the volume of this free flap after radical
parotidectomy reconstruction has been shown to be reduced by only 8% [28]. Other options available for free
flap reconstruction include latissimus dorsi free flap and
superficial inferior epigastric artery free flap [29]. However, the latissimus dorsi free flap is more difficult to
harvest concurrently and is likely to result in higher
postoperative donor site morbidity. The superficial inferior epigastric artery free flap has much smaller caliber
vessels which may increase risk of flap failure and decrease ability for postoperative flap monitoring. For cases
with facial nerve sacrifice, it is surprising that only 25.5%
of patients have documented reinnervation procedures,
and only 24% have documented reanimation procedures
(Table 2). This low rate of facial reinnervation and reanimation following radical parotidectomy is also underscored in a recent review of NSQIP [30]. This leads to
the question of whether these procedures fail to be
coded and thus detected by the database or whether
these procedures are truly not performed commonly in
cases with facial nerve sacrifice. There is encouraging
data that would encourage immediate reinnervation and
reanimation in these cases [31].
Surgical site infection following parotidectomy is not a
well-researched complication, likely due to its low incidence. Our study showed an incidence of 2.7%, with the
highest predictors of SSI being concurrent free flap and
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pre-existing bleeding disorder. This would provide evidence that the mechanism for post-parotidectomy
wound infections is from hematoma formation that
becomes subsequently infected. Following this logic, as
post-parotidectomy hematomas are more common in
males due to rich blood supply of hair follicles in the
overlying dermis, it is not surprising that males were
also found to have significantly increased risk for developing SSI compared to females. In fact, in the literature,
there been an association with drain output greater than
50 ml in 24 h to be predictive of surgical site infection
[32, 33]. Since abdominal fat grafts have also been
shown to be associated with increased surgical site
drainage [20] and larger defects are more likely to
prompt contour adjustments, it is concordant that volume restoration was associated with a higher rate of SSIs
in our dataset (Table 4).
Poor wound-healing may also contribute to SSI and
wound dehiscence and this process may be exacerbated by
the systemic factors seen to increase risk for both of these
outcomes in this study. These factors include comorbid
COPD, diabetes, and a smoking history. These results
contradict a recent single-center study which did not find
an association with diabetic status and post-parotidectomy
surgical site infection [34]. However, they are consistent
with previous data on smoking increasing surgical complication risk following parotidectomy [6]. Many institutions,
including our own, preoperatively counsel patients on the
importance of smoking cessation prior to parotidectomy
and this study provides substantiated data to help further
justify and aid this counseling process.
Medical complications that do not involve the surgical
site are not well-studied and the data provided here
point towards a relatively low incidence of these adverse
outcomes. These complications appear to be associated
with advanced age, malignancy, weight loss, wound infection, concomitant corticosteroid use, free flap reconstruction, and undergoing surgery in an inpatient setting
(Additional file 2 Table S2). These associated factors are
unsurprising as older patients and those who have malignancy or require free flap reconstruction would be expected to be at an elevated risk preoperatively and those
with a higher ASA (American Society of Anesthesiologists) physical status level would be more likely to have
their surgery performed at a hospital-based setting.
Limitations

This study is subject to several limitations inherent to
the use of a large national database. The most notable of
these is the absence of procedure-specific outcomes such
as facial nerve paresis and the inability to assess complications beyond the 30-day postoperative period. There is
also the issue of procedures that are not coded correctly.
For example, in this dataset, facial nerve monitoring was
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only coded in 2.4% of cases, despite this being a routine
aspect of parotidectomy and is considered by many surgeons to be the standard of care. The small incidence of
facial nerve monitoring in this study is likely due to lack
of proper documentation and exemplifies a fundamental
limitation of using this retrospective dataset. Further, the
possibility of confounding cannot be excluded given the
absence of disease-specific variables such as tumor stage.
However, the data captured by NSQIP has been shown
to be of high validity, particularly when compared to
comparable population datasets derived from administrative claims data [35]. The method of data collection is
worth noting, as NSQIP is unique in utilizing trained
clinical reviewers to extract data from the medical record. As a result, NSQIP data has been shown to capture
61% more complications than comparable population
datasets derived from administrative claims data [35].
However, this method of data collection may in part explain the lower than expected rate of concurrent procedures such as nerve monitoring, as the associated CPT
code may not have been clearly documented in the medical record. While the strength of this analysis lies in the
statistical power afforded by the NSQIP database, these
results should be interpreted with these limitations in
mind.

Conclusions
As the US health care system moves towards a qualitybased outcome model, the information available in this
data set regarding readmission and reoperation rates are
of importance for risk-stratification of these patients.
Not only surgeons, but hospital administrators will be
interested in readmission rates for this relatively safe
procedure. Thus, being aware of these variables (Table
4) may help with patient selection for inpatient versus
outpatient surgery as well as frequency and duration of
follow up for patients with these identified risk factors.
Further study is necessary to determine the cause of readmission and reoperation for these patients and
whether these readmissions are avoidable.
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